What evidence is there to support the use of the WATCHMAN device as an alternative to anticoagulation for patients with contraindications?
Data on the use of the WATCHMAN device in patients with contraindications to anticoagulation is very limited, and a randomized controlled study comparing this device with oral anticoagulation is currently unavailable. Furthermore, dual antiplatelet therapy (DAPT) is needed for at least 6 weeks after the procedure, potentially exposing the patient to increased risk of bleeding.